The Distinctive Features behind the Aggressiveness of Oral and Cutaneous Squamous Cell Carcinomas

被引:5
|
作者
Alonso-Juarranz, Miguel [1 ,2 ]
Mascaraque, Marta [3 ,4 ]
Carrasco, Elisa [3 ,5 ]
Gracia-Cazana, Tamara [6 ]
De La Sen, Oscar [1 ,2 ]
Gilaberte, Yolanda [6 ]
Gonzalez, Salvador [5 ,7 ]
Juarranz, Angeles [3 ,5 ]
Falahat, Farzin [1 ,2 ]
机构
[1] Hosp Clin San Carlos, Oral & Maxillofacial Surg Serv, Madrid 28040, Spain
[2] Univ Complutense, Fac Med, Surg Dept, Madrid 28040, Spain
[3] Univ Autonoma Madrid, Dept Biol, Madrid 28049, Spain
[4] Miguel Servet Univ Hosp, Translat Res Unit, Inst Invest Sanitaria Aragon IIS, Zaragoza 50009, Spain
[5] Inst Ramon y Cajal Invest Sanitaria IRYCIS, Dept Expt Dermatol & Skin Biol, Madrid 28034, Spain
[6] Miguel Servet Univ Hosp, Dept Dermatol, Inst Invest Sanitaria Aragon IIS, Zaragoza 50009, Spain
[7] Univ Alcala, Dept Med & Med Specialties, Madrid 28871, Spain
关键词
oral squamous cell carcinoma; cutaneous squamous cell carcinoma; tumor microenvironment; cancer-associated fibroblasts; immune cells; tertiary lymphoid structures; EPITHELIAL-MESENCHYMAL TRANSITION; GENOMIC CHARACTERIZATION; FIBROBLAST ACTIVATION; CANCER; HEAD; RISK; PROGRESSION; INVASION; THERAPY; MACROPHAGES;
D O I
10.3390/cancers15123227
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary In this review, we describe the recent studies that define the genetic alterations and composition of the stroma of oral and cutaneous squamous cell carcinomas (OSCC and CSCC, respectively). Mutations in tumor suppressor genes and protooncogenes cooperate in determining the differentiation, aggressiveness, and metastatic potential of these types of cancers. Driver mutations in tumor suppressor genes are more frequently observed in OSCC than CSCC. We also describe the differential composition of the tumor microenvironment and how this influences the aggressiveness of each tumor type. Although both OSCC and CSCC tumors are highly infiltrated by immune cells, high levels of tumor-infiltrating lymphocytes have been more frequently reported as predictors of good responses in OSCC than CSCC. Squamous cell carcinomas arise from stratified squamous epithelia. Here, a comparative analysis based on recent studies defining the genetic alterations and composition of the stroma of oral and cutaneous squamous cell carcinomas (OSCC and CSCC, respectively) was performed. Both carcinomas share some but not all histological and genetic features. This review was focused on how mutations in tumor suppressor genes and protooncogenes cooperate to determine the differentiation, aggressiveness, and metastatic potential of OSCC and CSCC. In fact, driver mutations in tumor suppressor genes are more frequently observed in OSCC than CSCC. These include mutations in TP53 (encoding pP53 protein), CDKN2A (encoding cyclin dependent kinase inhibitor 2A), FAT1 (encoding FAT atypical cadherin 1), and KMT2D (encoding lysine methyltransferase 2D), with the exception of NOTCH (encoding Notch receptor 1), whose mutation frequency is lower in OSCC compared to CSCC. Finally, we describe the differential composition of the tumor microenvironment and how this influences the aggressiveness of each tumor type. Although both OSCC and CSCC tumors are highly infiltrated by immune cells, high levels of tumor-infiltrating lymphocytes (TILs) have been more frequently reported as predictors of better outcomes in OSCC than CSCC. In conclusion, OSCC and CSCC partially share genetic alterations and possess different causal factors triggering their development. The tumor microenvironment plays a key role determining the outcome of the disease.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Quantifying desmoplasia in cutaneous squamous cell carcinomas
    Essien, S.
    Hirakawa, Y.
    Zhan, Q.
    Abdelmoula, W. M.
    Agar, N.
    Piris, A.
    Yu, K. K.
    Schmults, C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S116 - S116
  • [22] Cutaneous squamous cell carcinomas in epidermolysis bullosa
    Lorenz, Judith
    AKTUELLE DERMATOLOGIE, 2023, 49 (03) : 88 - 88
  • [23] Cutaneous Squamous Cell Carcinomas of the Lower Extremities Show Distinct Clinical and Pathologic Features
    Solus, Jason F.
    Murphy, George F.
    Kraft, Stefan
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2016, 24 (01) : 29 - 36
  • [24] SUNLIGHT EXPOSURE AND RISK OF DEVELOPING CUTANEOUS AND ORAL SQUAMOUS CELL CARCINOMAS IN WHITE CATS
    DORN, CR
    TAYLOR, DON
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1971, 46 (05) : 1073 - &
  • [25] Distinct transcriptomic landscapes of cutaneous basal cell carcinomas and squamous cell carcinomas
    Wan, Jun
    Dai, Hongji
    Zhang, Xiaoli
    Liu, Sheng
    Lin, Yuan
    Somani, Ally-Khan
    Xie, Jingwu
    Han, Jiali
    GENES & DISEASES, 2021, 8 (02) : 181 - 192
  • [26] Biomarker and Pathologic Predictors of Cutaneous Squamous Cell Carcinoma Aggressiveness
    Khandelwal, Alok R.
    Ma, Xiaohui
    Egan, Paige
    Kaskas, Nadine M.
    Moore-Medlin, Tara
    Caldito, Gloria
    Abreo, Fleurette
    Gu, Xin
    Aubrey, Lurie
    Milligan, Edward
    Nathan, Cherie-Ann O.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2016, 155 (02) : 281 - 288
  • [27] Merkel cell polyomavirus infection in cutaneous squamous cell carcinomas
    Rollison, Dana E.
    Giuliano, Anna R.
    Messina, Jane L.
    Fenske, Neil A.
    Cherpelis, Basil S.
    Sondak, Vernon K.
    Roetzheim, Richard G.
    Iannacone, Michelle R.
    Fulp, William
    Michael, Kristina M.
    Waterboer, Tim
    Gheit, Tarik
    Tommasino, Massimo
    Pawlita, Michael
    CANCER RESEARCH, 2011, 71
  • [28] Basal Cell and Cutaneous Squamous Cell Carcinomas: Diagnosis and Treatment
    Firnhaber, Jonathon M.
    AMERICAN FAMILY PHYSICIAN, 2020, 102 (06) : 339 - 346
  • [29] Splicing Machinery Is Impaired in Oral Squamous Cell Carcinomas and Linked to Key Pathophysiological Features
    Sanjuan-Sanjuan, Alba
    Alors-Perez, Emilia
    Sanchez-Frias, Marina
    Monserrat-Barbudo, Jose A.
    Falguera Uceda, Mabel
    Heredero-Jung, Susana
    Luque, Raul M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
  • [30] ORAL ISOTRETINOIN THERAPY - USE IN A PATIENT WITH MULTIPLE CUTANEOUS SQUAMOUS-CELL CARCINOMAS AND KERATOACANTHOMAS
    LEVINEN
    MILLER, RC
    MEYSKENS, FL
    ARCHIVES OF DERMATOLOGY, 1984, 120 (09) : 1215 - 1217